Table 1.
Participant characteristics by sex.
| Characteristic |
Female (n = 69) |
Male (n = 189) |
P-value | Absolute standardized mean difference |
|---|---|---|---|---|
| Age, mean (SD), year | 42.6 (14.0) | 48.3 (13.7) | 0.003 | 0.42 |
| Highest education level | 0.01 | 0.46 | ||
| Less than HS | 4 (5.8) | 1 (0.5) | ||
| Some/completed HS | 19 (27.5) | 36 (19.1) | ||
| Some/completed university | 39 (56.5) | 111 (59.0) | ||
| Some/completed graduate education | 7 (10.1) | 40 (21.3) | ||
| (Missing) | 0 | 1 | ||
| Total household income | 0.002 | 0.65 | ||
| $29,999 under | 30 (47.6) | 53 (29.4) | ||
| $30,000–$59,999 | 23 (36.5) | 54 (30.0) | ||
| $60,000-$89,999 | 7 (11.1) | 29 (16.1) | ||
| $90,000 and up | 3 (4.8) | 44 (24.4) | ||
| (Missing) | 6 | 9 | ||
| Current employment status | 0.69 | 0.06 | ||
| Employed | 35 (53.0) | 104 (55.9) | ||
| (Missing) | 3 | 3 | ||
| Born in Canada | 0.32 | 0.14 | ||
| Yes | 47 (70.1) | 118 (63.4) | ||
| (Missing) | 2 | 3 | ||
| Inject drugs user | 8 (11.6) | 9 (4.8) | 0.08 | 0.25 |
| Non-prescription illicit drug user | 4 (5.8) | 27 (14.3) | 0.06 | 0.29 |
| Gender | <0.0001 | 5.70 | ||
| Woman | 64 (92.8) | 2 (1.1) | ||
| Man | 1 (1.4) | 162 (86.2) | ||
| Transgender | 0 (0.0) | 2 (1.1) | ||
| Two-spirit | 1 (1.4) | 8 (4.3) | ||
| Queer | 1 (1.4) | 11 (5.9) | ||
| Non-binary | 1 (1.4) | 3 (1.6) | ||
| Agender | 0 (0) | 0 (0.0) | ||
| Other | 1 (1.4) | 1 | ||
| (Missing) | 0 | 1 | ||
| MSM | <0.0001 | 2.95 | ||
| Yes | 3(4.4) | 164 (86.8) | ||
| (Missing) | ||||
| Ethnicity | 0.02 | 0.33 | ||
| White | 29 (42.6) | 110 (59.1) | ||
| BIPOC | 39 (57.4) | 76 (40.9) | ||
| (Missing) | 1 | 3 | ||
| Ethnicity subgroup | ||||
| African, Caribbean or Black community | 14 (20.3) | 16 (8.5) | 0.01 | 0.34 |
| Indigenous | 9 (13.0) | 3 (1.6) | 0.001 | 0.45 |
| Migrant | 3 (4.3) | 10 (5.3) | 1.00 | 0.04 |
| Received HIV diagnosis | 0.28 | 0.28 | ||
| 4 years ago and less | 14 (21.5) | 24 (13.0) | ||
| 5–9 years ago | 11 (16.9) | 26 (14.1) | ||
| 10–14 years ago | 8 (12.3) | 33 (17.8) | ||
| 15 years ago or more | 32 (49.2) | 102 (55.1) | ||
| (Missing) | 4 | 4 | ||
| On ARV | 1.00 | 0.01 | ||
| Yes | 67 (98.5) | 186 (98.4) | ||
| (Missing) | 1 | 0 | ||
| Hepatitis C | 0.36 | 0.12 | ||
| Yes | 5 (7.7) | 9 (4.8) | ||
| (Missing) | 4 | 1 | ||
| Diabetes | 0.02 | 0.31 | ||
| Yes | 16 (23.5) | 22 (11.9) | ||
| (Missing) | 1 | 4 | ||
| Kidney failure | 0.21 | 0.19 | ||
| Yes | 6 (9.0) | 8 (4.3) | ||
| (Missing) | 2 | 4 | ||
| Chronic liver disease | 1.00 | 0.01 | ||
| Yes | 4 (6.2) | 11 (5.9) | ||
| (Missing) | 4 | 3 | ||
| Chronic lung disease | 0.39 | 0.12 | ||
| Yes | 6 (9.1) | 11 (5.9) | ||
| (Missing) | 3 | 2 | ||
| Severe asthma | <0.0001 | 0.50 | ||
| Yes | 13 (19.4) | 7 (3.8) | ||
| (Missing) | 2 | 3 | ||
| Smoking | 0.01 | 0.44 | ||
| Yes | 23 (34.8) | 34 (18.5) | ||
| Not currently/in the past | 17 (25.8) | 79 (42.9) | ||
| Never | 26 (39.4) | 71 (38.6) | ||
| (Missing) | 3 | 5 | ||
| Vaping | 0.06 | 0.33 | ||
| Yes | 6 (9.2) | 26 (14.1) | ||
| Not currently/in the past | 15 (23.1) | 21 (11.4) | ||
| Never | 44 (67.7) | 138 (74.6) | ||
| (Missing) | 4 | 4 | ||
| Smoking cannabis | 0.38 | 0.20 | ||
| Yes | 15 (23.4) | 50 (27.5) | ||
| Not currently but in the past | 18 (28.1) | 62 (34.1) | ||
| Never | 31 (48.4) | 70 (38.5) | ||
| (Missing) | 5 | 7 | ||
| Consumption of cannabis or cannabinoid-based products (form other than smoking) | 0.58 | 0.15 | ||
| Yes | 13 (20.0) | 45 (24.6) | ||
| Not currently/in the past | 19 (29.2) | 43 (23.5) | ||
| Never | 33 (50.8) | 95 (51.9) | ||
| (Missing) | 4 | 6 |